首页> 外国专利> GANODERMA LUCIDUM EXTRACT CONTAINING QUANTITY OF LIPID-SOLUBLE COMPONENTS AND INHIBITING INDUCTION OF OSTEOPOROSIS TO PREVENT AND TREAT OSTEOPOROSIS

GANODERMA LUCIDUM EXTRACT CONTAINING QUANTITY OF LIPID-SOLUBLE COMPONENTS AND INHIBITING INDUCTION OF OSTEOPOROSIS TO PREVENT AND TREAT OSTEOPOROSIS

机译:含有大量脂溶性成分的灵芝提取物,并抑制诱导骨质疏松症预防和治疗骨质疏松症

摘要

PURPOSE: Provided is Ganoderma lucidum extract for the prevention and treatment of osteoporosis. The Ganoderma lucidum extract contains a large quantity of lipid-soluble components and inhibits the induction of osteoporosis. Therefore, the Ganoderma lucidum extract is used as prophylaxis agents or therapeutics for osteoporosis. CONSTITUTION: Ganoderma lucidum extract is obtained by extracting Ganoderma lucidum with ethylalcohol at 70-80 deg.C for 3-5 hours, followed by concentration at 20-40 deg.C under reduced pressure. The Ganoderma lucidum extract contains lipid-soluble components and inhibits the induction of osteoporosis. The Ganoderma lucidum extract is added, as active ingredient, to prophylaxis agents or therapeutics for osteoporosis.
机译:目的:提供灵芝提取物,用于预防和治疗骨质疏松症。灵芝提取物包含大量脂溶性成分,并抑制骨质疏松症的诱导。因此,灵芝提取物被用作骨质疏松症的预防剂或治疗剂。组成:灵芝提取物是通过在70-80℃下用乙醇提取灵芝3-5小时,然后在20-40℃下减压浓缩而获得的。灵芝提取物包含脂溶性成分并抑制骨质疏松症的诱导。将灵芝提取物作为活性成分添加到骨质疏松症的预防剂或治疗剂中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号